Status:
COMPLETED
Dexmedetomidine, Ketamine and Dexmetedomidine-Ketamine Combination for Control of Shivering During Regional Anaethesia
Lead Sponsor:
Assiut University
Conditions:
Shivering
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Shivering is defined as an involuntary, repetitive activity of skeletal muscles. The incidence of shivering has been found to be quite high, approximately 40-50% in different studies. It can double or...
Detailed Description
Shivering is a physiological response to core hypothermia in an attempt to raise the metabolic heat production. The main causes of intra and postoperative shivering are heat loss, increased sympatheti...
Eligibility Criteria
Inclusion
- This study will include adults between 18 and 60 years of age undergo elective lower abdominal and lower limb surgery using spinal anaesthesia.
- ASA grade I - II
Exclusion
- Patient refusal.
- Patients who have temperature over 37.3 or below 36 celsius degree.
- Known allergies to the study drugs.
- Contraindication to spinal anaesthesia as coagulopathy,
- patients with thyroid disease, Parkinson disease, dysautonomia, Raynaud syndrome, use of sedative-hypnotic agent or vasodilators.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT03302351
Start Date
October 1 2017
End Date
April 1 2018
Last Update
July 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghada Mohammmad Aboalfadl
Asyut, Egypt